DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
Drug Availability HPS Pharmacies wish to give notice that Mylan Australia is experiencing a supply interruption for Marevan® 5mg tablets as follows: Marevan® Tablets Warfarin sodium 5mg ARTG 12514 Normal supplies of Marevan® 5mg tablets are expected…
Read more
Drug Availability HPS Pharmacies wish to advise that Fresenius Kabi have provided an update on the availability of Fresofol® (propofol). During the COVID-19 pandemic, demand for critical medicines has increased significantly. In response, Fresenius Kabi…
Read more
Drug Discontinuation HPS Pharmacies wish to give notice that Eli Lilly is discontinuing Effient® as follows: Effient® Tablets Prasugrel 5mg ARTG 150809 Effient® Tablets Prasugrel 10mg ARTG 150810 Both strengths of Effient® will be deleted from the Australian…
Read more
Drug Availability HPS Pharmacies wish to give notice that Arrow Pharmaceuticals are experiencing an interruption to the supply of Artane® as follows: Artane® Tablets Trihexyphenidyl (benzhexol) hydrochloride 2mg ARTG 15125 Artane® Tablets Trihexyphenidyl (benzhexol) hydrochloride 5mg ARTG…
Read more
Drug Availability HPS Pharmacies wish to give notice that AstraZeneca has advised of a supply interruption to Pulmicort® and Symbicort® Turbuhalers® as follows: Product ARTG Expected Return Date Pulmicort® 100mcg 10063 Late May 2020 Symbicort® 100/6mcg 80875 Early June…
Read more
Drug Availability HPS Pharmacies wish to advise that the Therapeutic Goods Administration (TGA) has given notice of a supply shortage for multiple brands of metformin modified-release 500mg tablets (also referred to as extended-release or XR tablets)….
Read more
